New drug combo tested to shrink breast tumors before surgery
NCT ID NCT04113863
Summary
This study tested whether adding a drug called ATRA to standard hormone therapy (anastrozole) could better shrink early-stage breast tumors before surgery. It involved 76 postmenopausal women with a specific type of breast cancer (HR-positive/HER2-negative). The goal was to see if the combination treatment was more effective at stopping cancer cell growth during the 4-week period before their scheduled operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST Papa Giovanni XXIII
Bergamo, 24127, Italy
-
Ospedale Santa Maria della Misericordia di Udine
Udine, UD, 33100, Italy
Conditions
Explore the condition pages connected to this study.